PT141

Description

PT-141 (Bremelanotide) — Melanocortin Receptor Agonist

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It is supplied for in vitro laboratory research only.

Research context

Preclinical and in vitro literature has examined bremelanotide in receptor-binding assays targeting the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptor subtypes, including studies of G-protein coupled receptor signalling and downstream cyclic AMP pathway activation in transfected cell lines. Central nervous system receptor-distribution studies have also used this compound to characterise melanocortin receptor pharmacology. Comparative pharmacology studies have further examined its receptor-binding selectivity relative to other melanocortin receptor agonists within in vitro assay panels.

Specification

• Available sizes: 10mg
• Form: lyophilised powder
• Purity: ≥99% (HPLC)
• Testing: independently lot-tested by Horizon Analytical · Certificate of Analysis per lot

For laboratory research use only. This material is supplied to qualified researchers and institutions for in vitro investigational use. It is not a drug, food, cosmetic or medical device. It is not intended for human or veterinary use, for diagnosis, treatment, cure or prevention of any disease, or for any use outside a controlled laboratory environment. No statement on this site has been evaluated by the Food and Drug Administration. Keep out of reach of children.

Related Research

Compound family: Kisspeptin-10, Oxytocin Acetate, Melanotan II, AHK-Cu

Browse: Reproductive Biology Research · All Research Peptides

Reconstitution & Lab Testing: All products independently tested by Horizon Analytical. See our Reconstitution & Lab Testing FAQ. Reconstitution typically requires BAC Water.